September 2, 2020
Virtual Events    Webinars      Whitepapers      OnDemand Learning     Podcasts

1. US scientists release guidance on COVID-19 vaccine distribution Full story

2. NIH questions evidence backing FDA's emergency authorization for convalescent plasma as COVID-19 treatment Full story

3. US decision to abstain from WHO-backed vaccine initiative 'awkward, contradictory and self-defeating,' expert says Full story

4. Data analytics + hospital pharmacy = cash. Attend this pharma-focused virtual discussion to learn how big data can help hospitals survive the economic downturn.

5. Sanofi, Regeneron say rheumatoid arthritis drug Kevzara failed as COVID-19 treatment Full story

6. California legislature OKs bill to create state-run generic drug company Full story

7. Join us at Becker's first ever Pharmacy Virtual Forum - click here to register!

8. Mylan launches low-cost insulin biosimilar Full story

9. Congress to subpoena AbbVie for providing 'particularly poor' drug pricing documents Full story

10. AstraZeneca signing up patients for phase 3 COVID-19 vaccine trial Full story

11. Outcomes management in a new landscape — insights for dental groups. Click here to attend.

12. Daily COVID-19 stats, state-by-state:

How necessity and technology are transforming the patient experience

Identifying Dark Green Dollars During Challenging Times: How hospital CFOs track and influence revenue

What can your organization do to manage high-cost, innovative therapies now and in the future?

Companies to Know
Thank you to our key sponsors


Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

View our profile on LinkedIn Follow us on Twitter Like us on Facebook Check our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker's Hospital Review, A Becker's Healthcare Publication